AAIC 2024: Biomarker Combo May Predict Development of β-Amyloid Pathology in Alzheimer Disease
If proven, the biomarkers could identify people for trials of drugs that slow Alzheimer disease onset
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.